BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32448257)

  • 1. A cluster-randomized, non-inferiority trial comparing use of misoprostol for universal prophylaxis vs. secondary prevention of postpartum hemorrhage among community level births in Egypt.
    Anger HA; Dabash R; Hassanein N; Darwish E; Ramadan MC; Nawar M; Charles D; Breebaart M; Winikoff B
    BMC Pregnancy Childbirth; 2020 May; 20(1):317. PubMed ID: 32448257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing a home-based model of care using misoprostol for prevention and treatment of postpartum hemorrhage: results from a randomized placebo-controlled trial conducted in Badakhshan province, Afghanistan.
    Abbas DF; Mirzazada S; Durocher J; Pamiri S; Byrne ME; Winikoff B
    Reprod Health; 2020 Jun; 17(1):88. PubMed ID: 32503556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trial.
    Atukunda EC; Siedner MJ; Obua C; Mugyenyi GR; Twagirumukiza M; Agaba AG
    PLoS Med; 2014 Nov; 11(11):e1001752. PubMed ID: 25369200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misoprostol for primary versus secondary prevention of postpartum haemorrhage: a cluster-randomised non-inferiority community trial.
    Raghavan S; Geller S; Miller S; Goudar SS; Anger H; Yadavannavar MC; Dabash R; Bidri SR; Gudadinni MR; Udgiri R; Koch AR; Bellad MB; Winikoff B
    BJOG; 2016 Jan; 123(1):120-7. PubMed ID: 26333044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Misoprostol for Primary versus Secondary Prevention of Postpartum Haemorrhage - Do Costs Matter?
    Chatterjee S; Sarkar A; Rao KD
    PLoS One; 2016; 11(10):e0164718. PubMed ID: 27755601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Misoprostol in addition to routine treatment of postpartum hemorrhage: a hospital-based randomized-controlled trial in Karachi, Pakistan.
    Zuberi NF; Durocher J; Sikander R; Baber N; Blum J; Walraven G
    BMC Pregnancy Childbirth; 2008 Aug; 8():40. PubMed ID: 18718007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis.
    Gallos I; Williams H; Price M; Pickering K; Merriel A; Tobias A; Lissauer D; Gee H; Tunçalp Ö; Gyte G; Moorthy V; Roberts T; Deeks J; Hofmeyr J; Gülmezoglu M; Coomarasamy A
    Health Technol Assess; 2019 Feb; 23(9):1-356. PubMed ID: 30821683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral misoprostol for preventing postpartum haemorrhage in home births in rural Bangladesh: how effective is it?
    Hashima-E-Nasreen ; Nahar S; Al Mamun M; Afsana K; Byass P
    Glob Health Action; 2011; 4():. PubMed ID: 21845143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of misoprostol distributed to antenatal women to prevent postpartum haemorrhage after child-births: a stepped-wedge cluster-randomized trial.
    Ononge S; Campbell OM; Kaharuza F; Lewis JJ; Fielding K; Mirembe F
    BMC Pregnancy Childbirth; 2015 Nov; 15():315. PubMed ID: 26610333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxytocin via Uniject (a prefilled single-use injection) versus oral misoprostol for prevention of postpartum haemorrhage at the community level: a cluster-randomised controlled trial.
    Diop A; Daff B; Sow M; Blum J; Diagne M; Sloan NL; Winikoff B
    Lancet Glob Health; 2016 Jan; 4(1):e37-44. PubMed ID: 26718808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, randomized controlled trial to explore oral tranexamic acid as adjunct for the treatment for postpartum hemorrhage.
    Diop A; Abbas D; Ngoc NTN; Martin R; Razafi A; Tuyet HTD; Winikoff B
    Reprod Health; 2020 Mar; 17(1):34. PubMed ID: 32143721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women.
    Chaudhuri P; Biswas J; Mandal A
    Int J Gynaecol Obstet; 2012 Feb; 116(2):138-42. PubMed ID: 22100204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of intrauterine misoprostol during cesarean section in prevention of primary PPH, a randomized controlled trial.
    Alalfy M; Lasheen Y; Elshenoufy H; Elzahaby IM; Kaleem HW; El Sawah H; Azkalani A; Saber W; Rashwan ASSA
    J Matern Fetal Neonatal Med; 2020 May; 33(9):1459-1465. PubMed ID: 30176758
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized controlled trial comparing 400μg sublingual misoprostol versus placebo for prevention of primary postpartum hemorrhage.
    Zgaya R; Ghadhab I; Triki MA; Briki R
    Pan Afr Med J; 2020; 36():186. PubMed ID: 32952830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic misoprostol for the prevention of postpartum hemorrhage: a randomized controlled trial.
    Uncu Y; Karahasan M; Uyaniklar Ö; Uncu G
    Eur Rev Med Pharmacol Sci; 2015 Jan; 19(1):15-22. PubMed ID: 25635970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misoprostol for the management of postpartum bleeding: a new approach.
    Dabash R; Blum J; Raghavan S; Anger H; Winikoff B
    Int J Gynaecol Obstet; 2012 Dec; 119(3):210-2. PubMed ID: 22980431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advance distribution of misoprostol for prevention of postpartum hemorrhage (PPH) at home births in two districts of Liberia.
    Smith JM; Baawo SD; Subah M; Sirtor-Gbassie V; Howe CJ; Ishola G; Tehoungue BZ; Dwivedi V
    BMC Pregnancy Childbirth; 2014 Jun; 14():189. PubMed ID: 24894566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community-based distribution of misoprostol to prevent postpartum haemorrhage at home births: results from operations research in rural Ghana.
    Geller S; Carnahan L; Akosah E; Asare G; Agyemang R; Dickson R; Kapungu C; Owusu-Ansah L; Robinson N; Mensah-Homiah J
    BJOG; 2014 Feb; 121(3):319-25. PubMed ID: 24283350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rectal misoprostol versus intramuscular oxytocin for prevention of post partum hemorrhage.
    Shrestha A; Dongol A; Chawla CD; Adhikari RK
    Kathmandu Univ Med J (KUMJ); 2011; 9(33):8-12. PubMed ID: 22610801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral misoprostol for prevention of postpartum hemorrhage by paramedical workers in India.
    Chandhiok N; Dhillon BS; Datey S; Mathur A; Saxena NC
    Int J Gynaecol Obstet; 2006 Feb; 92(2):170-5. PubMed ID: 16371228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.